Eastman Chemical Company

NYSE:EMN Rapport sur les actions

Capitalisation boursière : US$8.7b

Eastman Chemical Croissance future

Future contrôle des critères 1/6

Eastman Chemical devrait augmenter ses bénéfices et son chiffre d'affaires de 15.9% et de 3% par an respectivement. Le BPA devrait croître de de 16.7% par an. Le rendement des capitaux propres devrait être 13.5% dans 3 ans.

Informations clés

15.9%

Taux de croissance des bénéfices

16.68%

Taux de croissance du BPA

Chemicals croissance des bénéfices17.3%
Taux de croissance des recettes3.0%
Rendement futur des capitaux propres13.52%
Couverture par les analystes

Good

Dernière mise à jour04 May 2026

Mises à jour récentes de la croissance future

Recent updates

Seeking Alpha • May 26

Eastman Chemical: Riding The Cycles To Shareholder Returns

Summary Eastman Chemical Company stands out as the top-quality option in the cyclical chemical sector, offering resilient dividend growth. EMN's U.S.-based assets provide insulation from geopolitical disruptions, enabling stable operations and pricing power amid sector volatility. EMN maintains a conservative payout ratio, supporting dividend growth even as peers like DOW and LYB cut dividends during downturns. Trading at an 11x forward PE, EMN offers potential for 22% total returns by 2027, with disciplined capital allocation and valuation awareness key to long-term success. Read the full article on Seeking Alpha
Article d’analyse • May 09

Eastman Chemical's (NYSE:EMN) Soft Earnings Don't Show The Whole Picture

Eastman Chemical Company's ( NYSE:EMN ) stock was strong despite it releasing a soft earnings report last week. We...
Mise à jour du récit • May 02

EMN: Supply Tightness And EV Glass Demand Will Support Earnings Recovery Potential

Analysts have made a modest upward adjustment to the Eastman Chemical price target to $96.01 from $95.39, reflecting updated views on the company following a mix of recent target hikes and one slight trim across major research firms. Analyst Commentary Recent Street research around Eastman Chemical has been active, with a cluster of price target changes and at least one upgrade, alongside a single modest trim.
Mise à jour du récit • Apr 18

EMN: Supply Tightness And Completed Buybacks Will Support Earnings Recovery Potential

Analysts have modestly raised their fair value estimate for Eastman Chemical to $95.39. This reflects updated price targets and recent research that points to slightly stronger revenue growth and profitability assumptions.
Mise à jour du récit • Apr 04

EMN: Future Earnings Recovery Will Struggle With Persistent Commodity Oversupply

Analyst price targets for Eastman Chemical have shifted higher by several dollars into the mid $70s to mid $80s range, as analysts factor in updated commodity chemical forecasts, evolving geopolitical supply constraints, and a slightly adjusted risk profile reflected in modest tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Eastman Chemical over recent months has featured a mix of higher price targets and recalibrated views on risk, as firms respond to commodity market forecasts, geopolitical bottlenecks in key shipping routes, and sector wide concerns around capacity and demand.
Mise à jour du récit • Mar 20

EMN: Supply Disruptions And Cash Returns Will Support Earnings Recovery Potential

Analysts nudged the fair value estimate for Eastman Chemical higher from $90.83 to $92.24, citing updated commodity chemical forecasts tied to supply disruptions and refined assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Eastman Chemical has leaned constructive, with several bullish analysts updating price targets and assumptions in response to both company specific factors and shifts in commodity markets.
Mise à jour du récit • Mar 05

EMN: Modest Upside As Oversupply And Deindustrialization Restrain Earnings Recovery Potential

Analysts have lifted their average price targets on Eastman Chemical by a mid single digit dollar range, with moves such as Evercore ISI taking its target to $75 from $70, as they factor in slightly different views on long term growth, profitability and valuation multiples, reflected in modest adjustments to revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary While several firms have nudged price targets higher on Eastman Chemical, there is also a thread of caution running through recent research that is worth keeping in mind when you think about risk and reward.
Mise à jour du récit • Feb 19

EMN: Cost Actions And Cash Returns Will Support Earnings Recovery Potential

Analysts have nudged their fair value estimate for Eastman Chemical up by about $1 to $90.83, pointing to refreshed assumptions around modestly positive revenue growth, a slightly lower discount rate, and a marginally reduced future P/E multiple as key drivers behind recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of upward price target revisions for Eastman Chemical, even as some firms fine tune assumptions to reflect mixed end markets.
Mise à jour du récit • Feb 04

EMN: Oversupplied Commodity Markets Will Constrain Future Earnings Recovery Potential

Analysts have raised their fair value estimate for Eastman Chemical from $60.00 to $67.00. This reflects updated assumptions for revenue growth, profit margins, and a higher future P/E multiple, following a series of recent price target increases across the Street.
Mise à jour du récit • Jan 21

EMN: Cost Savings And Free Cash Flow Will Support Earnings Recovery Potential

Narrative Update Analysts have trimmed their consolidated price expectations for Eastman Chemical by around $1. They are factoring in softer revenue growth assumptions, slightly lower future P/E multiples, and a mixed set of recent target changes that balance cautious industry views with confidence in cash generation and margin resilience.
Mise à jour du récit • Jan 07

EMN: Cost Savings And Asset Utilization Will Drive Earnings Recovery Potential

Analysts have trimmed their fair value estimate for Eastman Chemical to about $90 from roughly $95, reflecting slightly higher discount rate assumptions and somewhat softer profit margin expectations. They still point to cost savings, asset utilization ramps and solid free cash flow as key supports for their updated price targets around $73 to $75.
Article d’analyse • Jan 05

These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Mise à jour du récit • Dec 23

EMN: Cost Savings And Asset Utilization Will Support Stronger Free Cash Flow

Analysts have nudged their average price target for Eastman Chemical slightly higher to about $73 from roughly $72.75, citing expectations for 2026 earnings tailwinds from cost savings, improved asset utilization, and resilient free cash flow even through a sluggish demand backdrop. Analyst Commentary Bullish analysts highlight that, despite modest adjustments to price targets, the long term investment case for Eastman Chemical remains underpinned by 2026 earnings tailwinds, including structural cost savings and improved asset utilization that are expected to drive margin expansion and profit growth from 2025 onward.
Mise à jour du récit • Dec 09

EMN: Cost Savings And Asset Utilization Will Drive Earnings Higher From 2025

Analysts have modestly trimmed their price target on Eastman Chemical by about $2 per share to approximately $74, citing a still challenging macro backdrop but highlighting improving 2026 earnings visibility driven by cost savings, asset utilization tailwinds, and the company’s ability to sustain solid free cash flow through the current earnings trough. Analyst Commentary Recent Street commentary reflects a generally constructive stance on Eastman Chemical, with price targets clustered in the low to mid 70s and Buy ratings maintained even as estimates and targets are adjusted to reflect a tougher macro environment.
Mise à jour du récit • Nov 25

EMN: Cost Savings And Asset Utilization Will Drive Earnings From 2025

The average analyst price target for Eastman Chemical has edged slightly lower to approximately $73, down less than $1, as analysts cite both resilient free cash flow and ongoing cost-saving initiatives in the context of a mixed demand outlook. Analyst Commentary Recent analyst updates reflect a nuanced perspective on Eastman Chemical's outlook, with both bullish and bearish takeaways emerging from the latest price target revisions and research commentary.
Mise à jour du récit • Nov 09

EMN: Cost Savings And Asset Utilization Will Drive Earnings Upside Ahead

Eastman Chemical's analyst price target was adjusted slightly downward by $1.53 to $73.06, as analysts cite a focus on cash generation and persistent end-market sluggishness, even though earnings improvements are expected ahead. Analyst Commentary Recent analyst updates on Eastman Chemical reflect a mix of cautious optimism and ongoing concerns related to the company's valuation and execution in a challenging market environment.
Mise à jour du récit • Oct 26

Commodity End Markets And Recycling Initiatives Will Shape Recovery Prospects Ahead

Eastman Chemical's analyst price target has been reduced by approximately $1 to $74.59. Analysts cite persistent macro headwinds and weakening conditions in commodity and industrial end markets as key factors behind this revised outlook.
Mise à jour du récit • Oct 12

Molecular Recycling And Specialty Materials Will Expand Global Reach

Analysts have lowered their price target for Eastman Chemical from $86 to $75, citing expectations of softer revenue growth and a moderately higher discount rate. Analyst Commentary Bullish Takeaways Bullish analysts continue to maintain a Buy rating on Eastman Chemical, citing confidence in the company's longer-term fundamentals.
Article d’analyse • Aug 02

Eastman Chemical Company (NYSE:EMN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Eastman Chemical Company ( NYSE:EMN ) shareholders that were waiting for something to happen have been dealt a blow...
Article d’analyse • Jun 18

We Think Eastman Chemical (NYSE:EMN) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Seeking Alpha • Jan 26

Following Up On A Correctly-Rated Eastman Chemical Company In 2025 (Rating Upgrade)

Summary Eastman Chemical has underperformed recently but shows promise with improved valuation and strategic direction, making it a conservative "Buy" for 2025. The company’s strong fundamentals, diverse product portfolio, and focus on sustainability, especially in molecular recycling, position it well for future growth. Despite recent declines, Eastman’s operational improvements, share buybacks, and favorable macro trends suggest significant upside potential, with expected earnings growth in the coming years. I rate Eastman Chemical a "Buy" at a valuation target of $140/share, anticipating a 15% annualized return based on a 12.2x P/E multiple. Read the full article on Seeking Alpha
Seeking Alpha • Oct 14

Eastman Chemical: Difficult To See Upside At This Valuation (Rating Downgrade)

Summary Eastman Chemical Company has shown strong 2Q24 results, particularly in advanced materials, but its current valuation appears overvalued, leading to a “Hold” rating. The company's strategic focus on specialty products and de-commoditization, along with new assets, has improved margins and operational performance. Despite positive trends, macroeconomic pressures and weak underlying demand outside destocking pose challenges, with limited upside potential at the current valuation. Eastman Chemical remains a fundamentally sound and ESG-focused company, but better investment opportunities exist in the market, warranting caution. Read the full article on Seeking Alpha
User avatar
Nouveau récit • Aug 22

Transforming Challenges Into Opportunities With Green Chemical Recycling And Innovative Growth

Expansion in sustainable solutions like chemical recycling and the Tritan product line indicates potential for revenue growth and market share increase.
Seeking Alpha • Jul 10

Eastman Chemical Running In Place (Rating Downgrade)

Summary Eastman Chemical is a $11.1 billion market cap specialty chemicals company offering a 3.4% dividend. The company’s new focus is on molecular (plastic) recycling. It has just opened a plant in Tennessee and received a US government grant to build one in Texas. Eastman’s second-largest number of plants are in high-cost Europe (nine). However, it is geographically diversified with 16 US plants and several in Asia and Latin America. Read the full article on Seeking Alpha

Prévisions de croissance des bénéfices et des revenus

NYSE:EMN - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20289,6828357681,25810
12/31/20279,4247877241,15713
12/31/20269,1707206671,08713
3/31/20268,6393994981,000N/A
12/31/20258,752474424970N/A
9/30/20259,0246993951,008N/A
6/30/20259,2868324061,002N/A
3/31/20259,3629225751,136N/A
12/31/20249,3829056881,287N/A
9/30/20249,3448856041,199N/A
6/30/20249,1478836061,317N/A
3/31/20249,1089255231,360N/A
12/31/20239,2108945461,374N/A
9/30/20239,3765855201,379N/A
6/30/20239,8187083341,121N/A
3/31/202310,278692271956N/A
12/31/202210,580793364975N/A
9/30/202210,9011,170285948N/A
6/30/202210,9121,2206171,239N/A
3/31/202210,7818188241,420N/A
12/31/202110,4768571,0411,619N/A
9/30/20219,9685111,1441,595N/A
6/30/20219,3703211,0841,490N/A
3/31/20218,6414941,1081,500N/A
12/31/20208,4734781,0591,455N/A
9/30/20208,4924721,3251,720N/A
6/30/20208,6955771,2671,694N/A
3/31/20209,1348081,2601,680N/A
12/31/20199,273759N/A1,504N/A
9/30/20199,444767N/A1,573N/A
6/30/20199,666913N/A1,552N/A
3/31/20199,924999N/A1,573N/A
12/31/201810,1511,080N/A1,543N/A
9/30/201810,1371,537N/A1,449N/A
6/30/201810,0551,448N/A1,582N/A
3/31/20189,8531,396N/A1,570N/A
12/31/20179,5491,384N/A1,657N/A
9/30/20179,3751,009N/A1,401N/A
6/30/20179,197918N/A1,323N/A
3/31/20179,075881N/A1,386N/A
12/31/20169,008854N/A1,385N/A
9/30/20169,045862N/A1,569N/A
6/30/20169,205886N/A1,487N/A
3/31/20169,441928N/A1,584N/A
12/31/20159,648848N/A1,624N/A
9/30/20159,772740N/A1,509N/A
6/30/20159,738694N/A1,701N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de EMN ( 15.9% par an) est supérieure au taux d'épargne ( 3.5% ).

Bénéfices vs marché: Les bénéfices de EMN ( 15.9% par an) devraient croître plus lentement que le marché US ( 17% par an).

Croissance élevée des bénéfices: Les bénéfices de EMN devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de EMN ( 3% par an) devrait croître plus lentement que le marché de US ( 11.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de EMN ( 3% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de EMN devrait être faible dans 3 ans ( 13.5 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/06/01 03:59
Cours de l'action en fin de journée2026/06/01 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Eastman Chemical Company est couverte par 36 analystes. 13 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Sergey VasnetsovBarclays
Michael LeitheadBarclays
Paretosh MisraBerenberg